Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Merritt

Showing results (441-450 of 510) with videos related to

Pageof 51
Sort By:
Cancer Research|August 30, 2019
High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort ConsortiumLauren C Peres, Adrianne R Mallen, Mary K Townsend, et al.
Cancer Research|April 7, 2017
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort ConsortiumJennifer Ose, Elizabeth M Poole, Helena Schock, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 14, 2013
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controlsKathryn L Terry, Stalo Karageorgi, Yurii B Shvetsov, et al.
International Journal of Epidemiology|February 25, 2026
Longer-term aspirin use and subsequent ovarian cancer risk in the Ovarian Cancer Cohort ConsortiumLauren M Hurwitz, Katie M O'Brien, Mary K Townsend, et al.
Journal of Medicinal Chemistry|September 29, 2006
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferaseJürgen Bosch, Mark A Robien, Christopher Mehlin, et al.
British Journal of Cancer|September 6, 2017
Anti-Mullerian hormone and endometrial cancer: a multi-cohort studyRenée T Fortner, Helena Schock, Seungyoun Jung, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 23, 2025
Reproductive and Hormonal Factors and Thyroid Cancer Risk: Pooled Analysis of Prospective Cohort Studies in the Asia Cohort ConsortiumSayada Zartasha Kazmi, Aesun Shin, Sarah K Abe, et al.
Pageof 51

Showing results (441-450 of 510) with videos related to

Sort By:
Pageof 51
Cancer Research|August 30, 2019
High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort ConsortiumLauren C Peres, Adrianne R Mallen, Mary K Townsend, et al.
Cancer Research|April 7, 2017
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort ConsortiumJennifer Ose, Elizabeth M Poole, Helena Schock, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 14, 2013
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controlsKathryn L Terry, Stalo Karageorgi, Yurii B Shvetsov, et al.
International Journal of Epidemiology|February 25, 2026
Longer-term aspirin use and subsequent ovarian cancer risk in the Ovarian Cancer Cohort ConsortiumLauren M Hurwitz, Katie M O'Brien, Mary K Townsend, et al.
Journal of Medicinal Chemistry|September 29, 2006
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferaseJürgen Bosch, Mark A Robien, Christopher Mehlin, et al.
British Journal of Cancer|September 6, 2017
Anti-Mullerian hormone and endometrial cancer: a multi-cohort studyRenée T Fortner, Helena Schock, Seungyoun Jung, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Cancer Gene Therapy|May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)N Yen, C G Ioannides, K Xu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 23, 2025
Reproductive and Hormonal Factors and Thyroid Cancer Risk: Pooled Analysis of Prospective Cohort Studies in the Asia Cohort ConsortiumSayada Zartasha Kazmi, Aesun Shin, Sarah K Abe, et al.
Pageof 51